SBFM Sunshine Biopharma Inc. PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Sunshine Biopharma (SBFM) Stock: Buy, Sell, or Hold?

$2.70
-0.14 (-4.93%) â–ŧ
5d: -0.37% 30d: +1073.91% 90d: +141.07%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (43%)
Quality Score
33/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$0.29 – $2.84
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-0.3x CHEAP
vs 13.1x historical avg
Wall Street Target
$1120.00
+41381.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.53 / $2.96
Trend: Sideways
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: SBFM is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.

Get Alerted When SBFM Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: SBFM is currently trading at $2.70, which is considered slightly high relative to its 30-day fair value range of $0.29 to $2.84. From a valuation perspective, the stock is trading at a discount (Forward PE: -0.3) compared to its historical average (13.1). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, SBFM is showing sideways momentum. Immediate support is located at $2.53, while resistance sits at $2.96. Short-term momentum is weak, with the stock down 4.9% recently.

Market Sentiment: SBFM scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1120.00 (+41381.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $0.29 - $2.84
Company Quality Score 33/100 (SELL)
Volume Confirmation HIGH
Confidence Score 42.9%

Trading Range & Key Levels

30-Day Trading Range $0.29 - $2.84
Current vs Trading Range SLIGHTLY HIGH
Support Level $2.53
Resistance Level $2.96
Current Trend Sideways
Technical data as of Nov 13, 2026

Quantitative Signal Breakdown

  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.9%)
  • BULLISH: Trading 41381.5% below Wall St target ($1120.00)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.34
Wall Street Target $1120.00 (+41381.5%)
Revenue Growth (YoY) -1.6%
Profit Margin -16.5%
PE vs Historical -0.3 vs 13.1 CHEAP
Share SBFM Analysis

Share this live SBFM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (SBFM)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary: One bullish trader on StockTwits expresses optimism about $SBFM.
Key Retail Themes: Positive sentiment towards $SBFM
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:45 PM ET
Data refreshes hourly during market hours. Next update: 6:45 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SBFM.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences Iâ€Ļ
STRONG BUY
29 analysts
$208 30 SELL
ALKS
Alkermes Plc
STRONG BUY
20 analysts
$58 39 SELL
TEVA
Teva Pharma Industries Lâ€Ļ
STRONG BUY
15 analysts
$49 47 HOLD
AMLX
Amylyx Pharmaceuticals Iâ€Ļ
STRONG BUY
12 analysts
$43 55 HOLD
AQST
Aquestive Therapeutics Iâ€Ļ
STRONG BUY
9 analysts
$9 59 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive SBFM Research Pages
SBFM Technical Chart SBFM Price Prediction SBFM Intrinsic Value DCF SBFM Earnings Date SBFM Investment Advisor SBFM Fair Price Analyzer SBFM Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals